Actionable news
All posts from Actionable news
Actionable news in COLL: Collegium Pharmaceutical Inc,

Today is FDA action date for Collegium's Xtampza ER approval

Today is the FDA's PDUFA date for approving Collegium Pharmaceutical's (COLL -2%) NDA for lead product candidate Xtampza ER (oxycodone extended-release capsules), an abuse-deterrent oral formulation of the widely...